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Neurogenic Inflammation:
Additional Points
William Meggs's recent article, "Neuro-
genic Inflammation and Sensitivity to
Environmental chemicals" (EHP 101:234-
238), provides a useful introduction to a
rapidly growing area ofknowledge in phys-
iology and posits a number of interesting
hypotheses regarding the health effects of
airborne chemicals. Some specific technical
points, however, merit comment.
Meggs describes the common chemical
sense as "a nasalsensation provoked by air-
borne chemicals" (p. 234, my emphasis).
This statement is correct as far as it goes,
but it neglects to mention that the trigemi-
nal nerve also innervates the oral cavity and
that ingested irritants (e.g., capsaicin, the
irritant in hot peppers, and allyl isothio-
cyanate, the irritant in horseradish) trigger
some of the same reflexes as inhaled irri-
tants. Thus, so-called gustatory rhinitis
involves rhinorrhea, nasal congestion, and
facial sweating after ingestion of "hot"
(spicy) foods (1). As to whether the com-
mon chemical sense was only "recently
separated" from olfaction as a sensory
modality (p. 235), the 1990 study ofodor
and nasal pungency in anosmics cited by
Meggs (2) is but the latest in a series
stretching back over 80 years and utilizing
various tools to separate the two sensory
systems (3).
Neuropeptide release occurs in relation
to other types of airway reflexes, some of
which do, indeed, involve an efferent limb
coming from the central nervous system, as
portrayed in Meggs's Figure 2. Gustatory
rhinitis, for example, involves afferent
trigeminal sensory fibers and efferent facial
nerve cholinergic fibers and is blocked by
the preadministration of atropine (1). In
contrast to Figure 2, however, the axon
reflex (whereby neuropeptides are released)
is a primarily afferent process, involving
release of neuropeptides from varicosities
in sensory nerves (4). Thus, neuropeptide
release can be thought of as a local, as
opposed to a central, reflex. What is clear is
that a complex interrelationship exists
between local (neuropeptide-mediated)
and central (adrenergic, cholinergic, and
nonadrenergic/noncholinergic) airway
reflexes. Each ofthese mechanisms, as well
as mast-cell degranulation (atopy), is sub-
ject to various regulatory factors, ultimately
influencing upper and lower airway reac-
tivity to environmental stimuli.
Meggs briefly mentions the variety of
neuropeptides documented in human air-
ways (substance P, calcitonin gene-related
protein, neurokinin A, and others), but
then goes on to focus on the role of sub-
stance P. The relative distribution of neu-
ropeptides and their physiological actions
appear to vary across species, making gen-
eralizations difficult at this time (5). For
example, whereas substance P promotes
neutrophil and eosinophil chemotaxis and
adhesion, its role in mast cell function
appears to be that of potentiating other
stimuli, rather than as an independent
stimulus for degranulation, as Meggs sug-
gests (6).
One aspect ofthe relationship between
neurogenic and immunogenic inflamma-
tion not touched upon in the article is the
fact that individuals with a history ofatopy
seem to be at higher risk of reactivity to
airborne irritants, even when there is no
evidence of an allergic mechanism of
response. Thus, while both Bascom et al.
(5) and Cummings et al. (7) observed a
higher prevalence of environmental tobac-
co smoke (ETS)-related upper airway
symptoms amongsubjects with a history of
atopy, neither assays for allergic mediators
in nasal lavage fluid (5) nor skin test reac-
tivity to tobacco leaf extracts or tobacco
smoke condensates (8) suggests an allergic
mechanism of response. These data are
consistent with a role for neuropeptides in
the genesis ofETS-related nasal symptoms,
as well as a modulatory effect of atopy
upon neuropeptide release (9). Thus, atopy
may constitute one of the most important
"disorders of regulation of neurogenic
inflammation" referred to by Meggs (p.
236).
An understanding of respiratory tract
responses to irritant chemicals requires famil-
iarity with concepts in allergy/immunology,
sensory science, and toxicology. Meggs has
made an important and accessible contribu-
tion to the literature by discussing neuro-
genic inflammation as a component of the
airway response.
DennisShusterman
AirToxicology andEpidemiology Section
Office ofEnvironmental
Health HazardAssessment
California Environmental
ProtectionAgency
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Neurogenic Inflammation:
Literature on Toluene
Diisocyanate
I am writing in regard to the article by
William Meggs in the August 1993 edition
of EHP (101:234-238). I was surprised to
see that in a review article of this type, the
author made no mention ofthe work ofour
group on the well-known chemical sensitizer
toluene diisocyante and its action on cap-
saicin-sensitive primary afferents. For your
information, I enclose a list ofpapers in ques-
tion:
Mapp CE, Boniotti A, Graf PD, Chitano P,
Fabbri LM, NadelJA. Bronchial smooth muscle
responses are inhibited by ruthenium red and by
indomethacin. EurJ Pharmacol 200:73(1991).
Mapp CE, Boniotti A, Graf PD, Plebani M,
Masiero M, Fabbri LM, Ciaccia A. Role of
metabolites ofarachidonic acid in toluene diiso-
cyanate-induced contraction on guinea-pig
bronchi. Eur RespirJ 4:435(1991).
Mapp CE, Boniotti A, Papi A, Chitano P, Coser
E, Di Stefano A, Saetta M, Ciaccia A, Fabbri
LM. The effect ofcompound 48/80 on contrac-
tions induced by toluene diisocyanate in isolated
guinea-pig bronchus. EurJ Pharmacol 248:67-
73(1993).
Mapp CE, Boniotti A, Papi A, Chitano P, Saetta
M, Di Stefano A, Ciaccia A, Fabbri LM. The
effect of phosphoramidon and epithelium
removal on toluene diisocyanate-induced con-
tractions in guinea-pig bronchi. Eur Respir J
5:331-333(1992).
Mapp CE, Boniotti A, Papi A, Maggi CA, Di
Stefano A, Saetta M, Ciaccia A, Fabbri LM.
Effect ofbumetanide on toluene diisocyante-
induced contraction in guinea-pig airways.
Thorax 48:63-67(1993).
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